$2.02
-0.90-30.82%
마지막 업데이트: Oct 2, 7:51 PM
$1.99
-0.93-31.68%
Benzinga
Benzinga
Benzinga
토요일, 10월 03
Benzinga
© 2026 Benzinga | All Rights Reserved
Foghorn Therapeutics (FHTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.23 | $-0.31 | $-0.27 | $-0.30 |
| Actual | $-0.10 | $-0.29 | $-0.34 | $-0.25 |
| Surprise | +56.5% | +6.45% | -25.9% | +16.7% |
| Revenue | ||||
| Estimate | $8.0M | $8.2M | $8.9M | $6.9M |
| Actual | $16.1M | $3.3M | $9.2M | $8.2M |
| Surprise | +101.6% | -60.2% | +3.32% | +17.4% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.23 | $-0.22 | $-0.20 | $-0.14 |
| Revenue | ||||
| Consensus | $7.9M | $8.3M | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.10 | $-0.23 | 56.5 % |
| Q1 | May 7, 2026 | $-0.29 | $-0.31 | 6.45 % |
| Q4 | Mar 11, 2026 | $-0.34 | $-0.27 | -25.9 % |
| Q3 | Nov 5, 2025 | $-0.25 | $-0.30 | 16.7 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $16.07M | $7.97M | 101.6 % |
| Q1 | May 7, 2026 | $3.27M | $8.20M | -60.2 % |
| Q4 | Mar 11, 2026 | $9.25M | $8.95M | 3.32 % |
| Q3 | Nov 5, 2025 | $8.15M | $6.94M | 17.4 % |